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he Challenge of Left
ain Stenosis*
ruce W. Lytle, MD, FACC
leveland, Ohio
he purposes of invasive, anatomic treatments for patients
ith coronary atherosclerosis are to relieve symptoms and to
rolong life expectancy. When the patient’s issues revolve
round symptom status, that patient advises the physician of
heir symptomatic level, the extent to which these symp-
oms limit their life, and the physician then advises the
atient about treatment options. If one treatment does not
ork, another is usually available. When the issue is life
xpectancy, the situation is different. Physicians bear the
esponsibility for advising the patient about the future
ikelihood of death, an irrevocable event, associated with
arious treatment strategies. The higher the risk of death
ssociated with the condition, the greater the responsibility
or accurate recommendations about the future and the
reater the importance of the data physicians base those
ecommendations on.
See page 236
Randomized and nonrandomized trials have shown that
ypass surgery prolongs the life expectancy of patients with
evere coronary artery disease when compared with medical
herapy (1,2). The clear demonstration of the survival
enefit of surgery does not apply to all patients even with
ultivessel disease but specifically to high-risk subsets
ncluding patients with a positive stress test, abnormal left
entricular systolic function, a proximal left anterior de-
cending coronary artery stenosis, and left main coronary
rtery disease. Left main coronary artery stenosis, in
articular, has been repeatedly documented to have a
igh association with death in the absence of anatomic
reatment (1).
Percutaneous coronary intervention (PCI) has been
hown to improve the life expectancy of some subsets of
atients with acute coronary syndromes when compared
ith medical therapy. The impact of PCI on the life
xpectancy of patients with chronic coronary artery disease
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-i
ions or the American College of Cardiology.
From The Cleveland Clinic, Cleveland, Ohio.s less assured, and multiple trials and analyses have been
onducted with the goal of establishing the principle that
he use of PCI as an initial invasive therapy does not
ompromise long-term survival. Randomized trials compar-
ng PCI and surgery in the treatment of low-risk patients
ith chronic coronary artery disease have shown either no
ifference in survival or a small advantage for surgery. The
OURAGE (Clinical Outcomes Utilizing Revasculariza-
ion and Aggressive Drug Evaluation) trial, a trial random-
zing relatively low-risk patients (with, however, a high
ncidence of proven ischemia) to PCI versus optimal med-
cal therapy has shown no survival advantage for PCI to
ate. Retrospective observational risk-adjusted studies com-
aring PCI and surgery, and inclusive of heterogeneous
atient samples spanning multiple risk categories such as the
eports from the New York State database, do appear to
how survival differences in favor of surgery (3). These
ifferences increase with time, increase with increasing
xtent of coronary artery disease, and have been persistent
nto the era of drug-eluting stents (4). The New York State
egistries have excluded patients with significant left main
oronary artery stenosis.
The study reported by White et al. (5), in this issue of
ACC: Cardiovascular Interventions, is a single-center retro-
pective observational risk-adjusted study comparing PCI
nd surgery for the treatment of chronic coronary athero-
clerosis in patients with left main stenosis. The authors,
nd others, have demonstrated that the procedural safety of
tenting for left main stenosis is consistently achievable.
owever, the demonstration of the long-term safety of
tenting as an anatomic treatment for left main stenosis has
ot been achieved by these data. The current study does not
ontain enough patients followed for long enough to estab-
ish the principle that left main stenting is protective against
he end point of death. The mean follow-up of patients after
CI in this study was 1 year and that of surgically treated
atients 2 years. The report does not list the number of
eath and events that occurred, but it appears that the total
umber of deaths that occurred in the surgical group was
bout 11 and those after PCI was about 28. The number of
vents determines the effective sample size, and the number
f events in this sample size is effectively very small.
These are not just technical details, as the sample size
mpacts strongly on conclusions about statistical significance
nd appears to account for some apparent dilemmas con-
erning the data. A cursory glance at the report survival
urves detects trends toward advantage for the surgical
roups that are not statistically significant. The risk-
djusted relative risk of mortality of PCI over that of surgery
as nearly 2-fold (1.93) but was not statistically significant
p  0.10), whereas a lesser relative risk (1.83) of major
dverse cardiovascular and cerebrovascular events was sig-
ificant (p  0.05). This difference is entirely based on anncreased number of events.
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Editorial Comment
247These types of considerations may also explain the
pparent discrepancy between the “high-risk” group who
xperienced improved survival with surgery and the “lower-
isk” group whose survival was equivalent. The lower-risk
atients overall have fewer events out to 30 months after
peration, and even if mortality is doubled in the PCI
roup, differences are not apparent at that time interval.
High-risk” patients experience more events overall, and
ith a similar increase in risk after PCI, the differences in
utcomes become more apparent. In studies of mortality
omparing varying surgical strategies, such as vein grafting
ersus internal mammary artery grafting, it has often been
oted that “lower-risk” patients just take a longer time for
isk differences to become apparent.
The identification of risk categories is itself a complex
ndertaking and will be important in the construction and
nalyses of randomized trials studying the impact of treat-
ent on patients with left main stenosis. In this study, risk
tratification groups were developed with data pertaining to
urgically treated patients. Certainly, this is a reasonable
lace to start since comparable data do not exist regarding
he treatment of patients with left main stenosis with PCI,
ut variables impacting on risk with surgical treatment may
e different than those impacting on risk after PCI. Indeed,
he authors believe this to be true since the patients selected
or surgery and selected for PCI were different in many
ays. It is notable concerning this study, however, that the
natomic extent of coronary disease did not appear to be
ncluded in the propensity score or other risk factor analyses.
his is surprising since we have identified the anatomic
xtent of coronary disease as a factor impacting on the
urgical risk of the treatment of patients with left main
tenosis, and it would seem intuitively that the extent of
isease might affect long-term PCI outcomes even more
han surgical outcomes (6). Late clinical events after PCI
ave been shown to often be related to anatomic events in
onstented but atherosclerotic coronary segments. It is not
mpossible to imagine that left main stenting might be an
ffective treatment for isolated left main stenosis considering
he decreased risk of restenosis associated with the drug-
luting stent-clopidogrel strategy. Most patients, however,
o not have isolated left main stenosis, and the impact of
ore extensive disease on long-term outcome will be
mportant to assess.
Tremendous strides have been made in the safety of all
ypes of coronary interventions including those for left main
tenosis, and the decrease in stent-related restenosis associ-
ted with drug-eluting stents is well documented and
mportant, even though the impact of the use of drug-
oated stents on survival is still uncertain (7). The advances
ffer opportunities. One opportunity may be left maintenting for patients also undergoing bypass grafting in an
ttempt to ameliorate the long-term incremental risk for left
ain stenosis. Another may be the total interventional
reatment for subsets of patients with left main stenosis as
escribed in this study. Further follow-up of the patient
ubsets studied in this report by the authors will produce a
aluable resource. In the foreseeable future, it is likely that
he interventional and surgical treatment of left main
tenosis will be complementary. The challenge will be to
issect out those subsets of patients who fare particularly
ell with interventional treatment or particularly well with
urgery. This task will require large patient subsets, long
ollow-up, and careful analyses. The procedure-related mor-
idity of bypass surgery is an important disadvantage for
any elderly patients, as pointed out by the authors. The
isadvantage of stenting relates to the life-threatening
haracter of left main stenosis and the uncertainty concern-
ng the positive impact of stenting for these patients. It is
ogical to believe that left main stenting will help to prolong
ife expectancy in some patient subsets. Our challenge is to
dentify who those patients are.
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